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Summary Adhesion molecules are thought to play a vital role in the induction and maintenance of tissue
differentiation and their loss or down-regulation has been implicated in the neoplastic process. Recent studies
have shown that the morphoregulatory activites are a consequence of interactive processes between several cell
adhesion molecules rather than the function of a single molecule. Therefore, we have investigated a panel of
adhesion molecules including members of the integrin, cadherin and immunoglobin superfamily in colorectal
cancer. Twenty-eight consecutive colorectal adenocarcinomas were stained using an avidin-biotin indirect
immunoperoxidase technique. Our results showed a consistent loss of the oc2 and PI integrin subunits
(21/28 = 75% and 22/28 = 78.6% respectively) and a decrease in expression of E-cadherin in 5/5 poorly
differentiated adenocarcinomas. Carcinoembryonic antigen expression was preserved but with basolateral
accentuation seen in tumours. There was no statistical correlation with Dukes' stage.
These results provide further evidence that in colorectal cancer there is a widespread deregulated expression
of cell-cell and cell-matrix adhesion molecules. Changes in the expression and function of adhesion molecules
which regulate growth and differentiation may play a role in the behaviour of colorectal cancer.
Cell-cell and cell-matrix interactions play an essential role in
the induction and maintenance of a differentiated epithelial
cell phenotype. Research into the process of tissue
differentiation from an enbryological viewpoint has received
much attention. More recently developmental biology has
provided us with many concepts which are applicable to
neoplastic transformation, tumour invasion and metastasis.
Such similarities have led us to believe that carcinogenesis
may result as a disruption of normal tissue organisation and
structure whose control is both hierarchial and dynamic.
Intercellular and cell-substratum interactions mediated by
adhesion molecules are likely to play a part both in the
structural morphology and functional differentiation of the
tissue and therefore a loss in this control mechanism may
well facilitate the neoplastic process (Crossin, 1991).
There are four main groups of adhesion molecules, inte-
grins, cadherins, the immunoglobulin superfamily and lecams
(selectins) (Hynes & Lander, 1992). Integrins and cadherins
are the prime mediators of cellular adhesion in normal and
transformed epithelial cells, integrins being largely respon-
sible for cell-substratum interaction and cadherins for
intercellular interaction (Hynes, 1992; Takeichi, 1991).
Integrins are heterodimers composed of a and P subunits
which are non-covalently bound. They are transmembrane
receptors whose function is dependent on the presence of
both subunits. At least 140 and 8p subunits have been de-
scribed with 20 combinations (Hynes, 1992). The P1 sub-
family (Very Late Antigens-VLA) associates with one of at
least eight different a chains to form receptors for extracel-
lular matrix proteins including fibronectin, laminin and col-
lagen (Hemler, 1990). P1 integrins have been shown to be
important in the glandular differentiation of a colorectal
cancer cell line (Pignatelli et al., 1992a).
The P3 and P5 subunits are more selective in their associa-
tions with a chains and form receptors for multiple ligands
such as vitronectin, fibrinogen and collagen. av links
preferentially with P3, but may also associate with P1, 135 or
P7. However, there is some evidence to suggest an alteration
in av affinity in malignant tissue towards P5 (Korhonen et al.,
1992).
Cadherins are transmembrane adhesion molecules that
require calcium for their function and connect cells in a
homotypic fashion (Takeichi, 1991). They are the prime
mediators of intercellular interaction, so much that inactiva-
tion of other cell-cell adhesion molecules has little effect on
cadherin function (Duband et al., 1987). Several subclasses of
cadherins have been described including E-cadherin
(epithelial cadherin, L-CAM, uvomorulin, Arc-1, cell CAM
120/80), P-cadherin (placental) and N-cadherin (neural). E-
cadherin is expressed by normal epithelial cells (Shiozaki et
al., 1991) and has also been implicated as a major deter-
minant in the differentiation of a colorectal carcinoma cell
line (Pignatelli et al., 1992a).
The immunoglobulin superfamily of adhesion molecules
consists ofmembers such as carcinoembryonic antigen (CEA)
and the neural cell adhesion molecule (N-CAM). N-CAM
has been shown to have homology with the DCC gene
(deleted in colorectal carcinoma), which is thought to be
important in colorectal tumorigenesis (Fearon et al., 1990).
CEA appears to function as an adhesion molecule both
mediating intercellular as well as cell-matrix interactions
(Benchimol et al., 1989; Pignatelli et al., 1990b).
We have investigated the immunolocalisation of a panel of
eight adhesion molecules in colorectal cancer and correlated
our findings to Dukes' stage and morphological
differentiation. The panel has been selected to include
members from the three main families of cell adhesion
molecules responsible for epithelial cell interactions as dis-
cussed above and which have been shown to be expressed in
a range of epithelial tissues. We also discuss the possible
functional interaction between the molecules studies as there
is now overwhelming evidence to support the theory that the
biological behaviour of tumour cells is the manifestation of a
composite of multiple adhesion interactions (Hynes &
Lander, 1992).
Materials and methods
Surgical resection specimens of 28 colorectal adenocar-
cinomas were obtained. Biopsies from the tumour centre, the
tumour-normal mucosal junction and normal colonic mucosa
10 cm distant from the tumour were taken. These were
immediately mounted in gelatin and snap-frozen in liquid
nitrogen. They were stored at - 20°C until sectioning. Cryos-
tat sections of 6 ;m thickness were cut, air dried and fixed in
cold 50% acetone/methanol for 10 min prior to staining.
Non-specific binding was reduced by pre-incubation with
20% normal rabbit serum for 15 min. An indirect avidin-
biotin immunoperoxidase technique was employed, using the
primary monoclonal antibodies shown in Table I. DH12,
HAS-6 and P5 were obtained in purified form and used at
20plg/ml concentration in phosphate buffered saline (PBS).
MP4F10, PR3B1O, 13C2, 23C6 and HECD-1 were obtained
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as culture supernatant and used neat. All the antibodies used
were in saturating concentrations determined from previous
immunohistochemical studies (Pignatelli et al., 1992; Stamp
& Pignatelli, 1991). 4-well Multiwell glass slides (C.A. Hend-
ley, Ltd.) pre-treated with 0.1% poly-l-lysine solution 1:10
were used for the immunostaining. Briefly, after pre-
incubation the primary antibody was placed on each section
for 45 min at room temperature. After three washes in PBS,
the second antibody, rabbit anti-mouse immunoglobulins
labelled with biotin in a mixture with normal human serum
was added for 30 min. After three further washes in PBS the
sections were incubated with the avidin-biotin complex
(Dakopatts, High Wycombe, UK) for another 30 min. Fol-
lowing three further washes in PBS, diaminobenzidine
(Sigma, St Louis, MO) was used to visualise the horseradish
peroxidase activity and the sections were then counterstained
with haematoxylin and dehydrated in a graded alcohol series.
After clearing with xylene, the sections were mounted in
DPX (British Drug Houses, Dagenham, Essex, UK). In con-
trol sections either the second or third layer alone was used
with omission of the primary antibody and no specific stain-
ing was observed in these cases. The positive controls were
the corresponding normal tissue itself, thus allowing direct
comparison to be made with tissue taken from the same
patient at the same time. Intensity of staining was then
assessed by two different observers (A.K.N., M.P.) on two
separate occasions using light microscopy and scored as fol-
lows: + + + (uniform and strong), + + (moderate), +
(weak and patchy) and - (negative). These were scored as 3,
2, 1 and 0 for purposes of statistical evaluation. Photomicro-
graphs were taken on an Olympus PM10 ADS system.
The histological diagnosis, grade, recorded as well,
moderate and poorly differentiated assessed by glandular
morphology and classification according to Dukes' stage
were based on assessment of corresponding tissue removed
for conventional analysis. Adhesion molecule expression, i.e.,
intensity of staining was then correlated with tumour grade
and stage. The x2 test with Yates' correction was employed
for this analysis. The numerical differences in expression
between normal and tumour tissue were also ranked and the
Mann-Whitney U test applied to the data.
Results
Twenty-eight consecutive cases of colorectal carcinoma
resected by one surgeon (P.B.B.) were used in this study.
Their clinicopathological characteristics were as shown in
Table II. There was a comparable number of metastatic and
non-metastatic cases (Dukes' A+B= 15, C = 13) but there
was a preponderance of cases in the moderately differentiated
category.
Normal colonic epithelium showed a similar pattern of
staining with the P1, a2, and a6 antibodies (Figure 1). There
was strong membrane and cytoplasmic staining observed in
all cases as well as strong endothelial immunoreactivity. In
Table II Clinicopathological characteristics
Patient
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Age
48
57
72
60
61
48
60
60
79
80
64
72
69
89
75
86
78
62
91
87
75
34
70
72
68
62
75
68
Sex
F
F
F
F
F
M
M
F
F
F
M
F
M
M
F
F
F
M
M
M
M
M
F
M
F
M
M
M
Site of
tumour
Rectum
Desc. colon
Asc. colon
Rectum
Rectum
Sigmoid
Desc. colon
Rectum
Rectum
Sigmoid
Desc. colon
Desc. colon
Rectum
Desc. colon
Asc. colon
Rectum
Asc. Colon
Caecum
Desc. colon
Sigmoid
Desc. colon
Asc. colon
Rectum
Desc. colon
Rectum
Sigmoid
Asc. colon
Rectum
Differentiation
Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Poor
Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Poor
Moderate
Moderate
Moderate
Moderate
Poor
Well
Moderate
Poor
Moderate
Moderate
Poor
Well
Table I Monoclonal antibodies
Monoclonal Antigen
antibody recognised Reference
DH12 P11 integrin subunit De Strooper et al.,
1988
HAS-6 a2 integrin subunit Tenchini et al., 1993
13C2 av integrin subunit Davies et al., 1989
23C6 avP3 integrin Davies et al., 1989
P5 P5 integrin subunit Ramaswamy &
Hemler, 1990
MP4F10 a6 integrin subunit Pignatelli et al., 1992b
PR3BI0 CEA/NCA Richman & Bodmer,
1987
HECD-1 E-cadherin Shimoyama et al.,
1989
Abbreviations: CEA, carcinoembryonic antigen; NCA, non- specific
cross-reacting antigen; E-cadherin, epithelial specific cadherin.
Figure 1 Normal and tumour tissue stained for a2 subunit
showing a down-regulation of expression in a moderately
differentiated carcinoma. (bar = 50 jAm).
Dukes'
stage
C
C
B
C
B
C
C
B
C
B
B
A
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B
C
B
C
C
C
C
A
A
C
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addition, J1 was present in fibroblasts and smooth muscle.
E-cadherin also demonstrated a distinct and evenly dis-
tributed expression at the intercellular borders and the apical
surfaces of the epithelial cells. Carcinoembryonic antigen
(CEA) staining was uniform with luminal staining observed
in all cases. In contrast, however, antibodies to av, xvJ33 and
,B5 showed marked differences in their staining patterns in
normal colonic epithelium. The av was expressed strongly in
endothelial tissues but weakly on the epithelium. Its reactivity
in the tissue stroma was much more predictable being present
in all cases except two. The av,B3 complex was absent from
the epithelium in 17/28 cases and showed only weak
immunoreactivity in the remainder. Its presence in the nor-
mal tissue stroma essentially matched that of the av subunit.
135 was weakly and inconsistently expressed in the stroma and
the epithelium (Figure 2).
The differences in staining observed between normal and
tumour tissue are shown in Tables III and IV. Although
many tumours exhibited heterogeneity of expression, some
clear patterns emerged. There was a consistent reduction in
expression of the a2 and 31 subunits with some cases show-
ing a complete loss (Figure 3). 75% and 78% of tumours
respectively showed a down-regulation (Figure 4). However,
neither of these results reached statistical significance when
analysed by Dukes' stage (Z' = 3.59, p = 0.06 7 = 0.44,
P = 0.50). Furthermore, after ranking the data in terms of
degree of down-regulation, again the figures failed to reach
significance (P = 0.43 and P = 0.45 respectively, Mann-
Whitney U test). Decreased immunoreactivity was observed
only in poor and moderately differentiated tumours. How-
ever, our sample size in the well differentiated category was
small and we are therefore unable to infer any conclusions
regarding a possible progressive loss of expression with
worsening differentiation.
E-cadherin exhibited decreased immunoreactivity in 8/28
tumours. No correlation with Dukes' stage was found
(Z2 = 3.32, P = 0.07) even after ranking level of expression
(P= 0.43). All the five poorly differentiated carcinomas
showed a loss of expression whereas in 20/23 well or
moderately differentiated tumours expression was preserved
(Figure 5).
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Figure 2 Expression of av, avP3 & P5 in normal stroma.
Figure 3 Poorly differentiated carcinoma showing a loss of exp-
ression for a2 subunit. (bar = 50pm).
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Table III Adhesion molecule expression
beta-i alpha-2 E-cadherin alpha-v, beta-3
Patient N T N T N T N T
I ++ - ++ + +++ +++ - _
2 ++ + +++ +++ ++++++ ++ _
3 ++ + +++ ++ + ++++ + +
4 ++ + ++ ++ + ++++ + -
5 + + +++ +++ ++++++ _ _
6 +++ + +++ ++ +++ +++ - _
7 + + +++ - +-++ ++ _
8 ++ - ++ + +++ +++ - _
9 ++ - +++ - +++ + + -
10 + + + + + ++ ++ ++++++ - -
11 ++ + +++ ++ +++ ++ ++ +
12 ++ - +++ +++ +++ +++ ++ ++
13 + + + + ++ + +++ ++ ++ ++
14 + + + + + + + ++ + ++++++
15 ++ + ++ + +++ +++ ++ -
16 + + - + + +- +++ + ++ +
17 ++ + +++ + +++ +++ - -
18 +++ ++ +++ ++ + -+ +++ - +
19 +++ +++ +++ - +++ +++ + +
20 +++ + +++ ++ +++ +++ - -
21 ++ - ++ - +++ + - -
22 ++ ++ +++ ++ +++ +++ - -
23 +++ ++ +++ ++ ++++++
24 +++ + +++ ++ +++ +
25 +++ + ++ - +++ +++
26 ++ ++ +++ ++ ++++++
27 +++ + +++ ++ +++ ++ - -
28 + + + + ++ + + ++++++
Table IV Adhesion molecule expression
alpha-v beta-5 alpha-6 CEA
Patient N T N T N T N T
I + - - ++ ++ + _
2 ++ - + - +++ +++ +++ +++
3 + + + - +++ +++ ++ ++
4 ++ + +++ + +++ +++ ++ ++
5 ++ - - - + +++ +++ +++
6 ++ + - - + +++ +++ +++
7 - - + + +++ +++ ++ ++
8 + + - - +++ +++ ++ ++
9 + - + - +++ ++ +++ ++
10 ++ + + - +++ ++ ++ ++
11 ++ - + - +++ +++ +++ +++
12 + ++ - + +++ +++ ++ ++
13 ++ ++ - ++ +++ +++ ++ ++
14 ++ - - - + +++ +++ +++
15 ++ - + + ++++++ ++ ++
16 + - ++ - ++++++ ++ ++
17 ++ - + ++ +++ +++ ++ ++
18 ++ ++ + ++ +++ +++ +++ +++
19 +++- + + ++++ ++ ++ ++
20 - - + ++ +++ +++ +++ ++
21 - - - - ++ ++ +++ +++
22 ++ - ++ + +++ ++ +++ +++
23 + ++ + - +++ ++
24 ++ + + - +++ ++ +++ +++
25 ++ ++ + ++ +++ +++ +++ ++
26 + + - - ++ ++ ++++++
27 ++ + + + +++ ++ ++ ++
28 + ++ + -
a6 expression was essentially preserved (Figure 6) with a
minimal reduction in expression (+ + + to + +) seen in five
tumours. CEA was down-regulated minimally in only 3/28
tumours with good luminal immunoreactivity (Figure 7) but
also a polarisation to the basolateral aspect of the cell.
Neither of these results corresponded with Dukes' stage or
morphological differentiation.
The greatest variability in expression was observed in the
stroma for av, avP3 and P5 subunits. (Table V). In the
tumour epithelium there was little change with weak
heterogeneous expression observed in those cases where it
had been noted in the corresponding normal tissue. However,
stromal av was reduced in 5/28 cases (Figure 8) with an
increase in expression in four tumours. avP3 was down-
regulated in ten cases (Figure 9) with a slight increase in
expression seen in only one tumour. P5 was lost from the
stroma in four cases but showed an increase in immunoreac-
tivity in eight cases (Figure 10). The overall results in this
group of integrins (Figure 11) therefore suggests a loss of the
av,B3 complex from the tumour stroma with an increase in
the 135 subunit. As av loss occurred in only 17% of tumours,
this implies that the av retained may be exhibiting a preferen-ADHESION MOLECULES IN COLORECTAL CANCER 511
Figure 5 E-cadherin expression in moderately differentiated car-
cinoma. (bar = 50gtm).
Table V Stromal expression of oav, avp3 & P5
alpha-v alpha-v, beta-3 beta-5
Patient N T N T N T
1 + + _ _ _ _
2 ++ ++ ++ + + ++
3 + + ++ +++ + _
4 ++ + +++ + +++ ++
5 +++ +++ - _ _ _
6 ++ ++ ++ _ _ _
7 + - + - + ++
8 - - _ _ + -
9 + + + - + +
10 ++ ++ + + +
11 ++ + ++ + + +
12 + ++ ++ ++ - +
13 ++ ++ ++ ++ ++
14 ++ - +++ +++ - +
15 ++ + ++ ++ ++ +
16 + + ++ ++ + ++ ++
17 + ++ + + ++ +
18 ++ +++ + ++ + ++
19 +++ ++ ++ ++ + +++
20 + + +++ + - ++
21 + ++ ++ ++ - _
22 - - ++ + + - +
23 ++ ++ + +
24 + + + + + ++
25 ++ ++ ++ ++ + +
26 + + ++ + ++
27 ++ ++ + + +
28 ++ ++ + - + +
Figure 6 a6 preservation along the membrane in moderately
differentiated tumour glands. (bar = 50JAm).
Figure 8 av expression in the stroma of a moderately differ-
entiated tumour. (bar = 50jum).
Figure 7 CEA staining particularly in the lumen of tumour
glands. (bar = 50ptm).
tial colocalisation with P5. Statistically, there was no correla-
tion with Dukes' stage with reduced or increased expression
for the av (x2=3.59, p=0.06 and X2=2.85, P=0.l1) and
the P5 subunits (X2 = 0.44, p = 0.5 and x2 = 3.31, P = 0.07).
The same result was gained after a ranking analysis. No
pattern relating to differentiation was discernible in this sub-
group.
Figure 9 Tumour stroma showing absence of avp3. (bar=
50jAm).512 A.K. NIGAM et al.
Figure 10 P5 overexpression in the stroma of a moderately
differentiated carcinoma. (bar = 50pm).
Discussion
The importance of cellular adhesion in the progression of a
malignant neoplastic process has long been recognised. Over
50 years ago it was proposed that a loss of intercellular
adhesion between tumour cells might be an important factor
in the spread of cancer. Fidler and Hart (1982) also con-
cluded that the ability to infiltrate surrounding tissues and
subsequently to detach and migrate may be related to altera-
tions in adhesiveness between cells and between cells and
their surrounding matrix. Furthermore, once the tumour cells
have entered the vasculature or lymphatic system their ability
to form metastasis may also be related to relative changes in
adhesion receptor expression. It has also been shown that
morphogenesis of normal and transformed cells is, in part,
governed by the functional expression of these molecules. In
particular, the beta-1 integrins and E-cadherin have been
shown to have regulatory properties over the differentiation
of a colorectal carcinoma cell line (Pignatelli et al., 1992a).
Although the functional cooperation between these molecules
is poorly understood, what is apparent is that the full evolu-
tion of any biological process involving adhesion molecules is
likely to involve a multitude of receptor-ligand interactions
(Hynes, 1992).
With the above in mind, we studied a panel of adhesion
molecules with a view to identifying those receptors which
beta-5
Alpha-v, beta-3
Alpha-v
were aberrantly expressed in the colonic neoplastic process.
We found that the P1 subunit was consistently lost or
decreased in the moderately and poorly differentiated car-
cinomas. In the same tumours the a2 subunit was similarly
affected. The a2P1 receptor binds to collagens, laminin and
fibronectin depending on the cell type (Kirchhofer et al.,
1990). The loss of this integrin in poorly differentiated col-
orectal carcinomas has been previously reported by one of
the authors (Pignatelli et al., 1990a), but studies in other
tumours and cell lines have reported different findings.
Koretz and co-workers (1991) found a marked heterogeneity
of expression for this integrin even in normal colonic mucosa
with a complete loss of antigen expression in two tumours.
No such loss has been seen in pancreatic cancer (Weinel et
al., 1992) and a role in tumour invasion has been implicated
by Chan et al. (1991) in their study on rhabdomyosarcoma
cells in which overexpression of (12p1 led to an increased
metastatic potential. This may be a reflection on the different
ligand specificities of a(213 already referred to or the
differences in epitopes recognised by the monoclonal
antibodies used in the various studies. As no correlation to
Dukes' stage was found in our study, inferences on the role
played by this integrin in invasion and metastasis are difficult
to make. The important point to note is that this was a
selective integrin loss as the a6 subunit was almost entirely
preserved. This latter finding is not in keeping with studies
on breast carcinomas nor renal cell carcinomas which show a
loss of this subunit in tumours where there is a high degree
of loss or disturbance of basement membrane (Pignatelli et
al., 1992b; Korhonen et al., 1992). The a6,13 integrin is a
receptor for the E8 fragment of basement membrane laminin
(Lotz et al., 1990), and in view of our apparent contradictory
findings for these two subunits, it follows that in colorectal
carcinoma (6 complexes with another P subunit. There is
strong evidence to support the preferential association of a6
with 134 in normal and transformed epithelial cells (Son-
nenberg & Linders, 1990; Lee et al., 1992) and we suggest
that in the colon this may well be the case.
The role of integrins in the loss of differentiation that
occurs in most tumours is well-established. Members of the
P1 integrin subfamily have been implicated in the process of
tubule formation in colonic epithelium and recently, func-
tional studies using a specific monoclonal antibodies in colon
carcinoma cell lines have identified the (12P1 heterodimer as
the key mediator of this process (Pignatelli & Liu, personal
communication). Thus, the loss ofa2P1 may explain, at least
in part, the disturbance of cell polarity and glandular or-
ganisation seen in poorly differentiated colorectal adenocar-
cinomas.
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Figure 11 Stromal changes in expression of a1v, otvP3 & P5.
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In this paper we report for the first time the distribution of
av, P5 and the heterodimer axv,3 in colorectal cancer. xvP3 is
the classical vitronectin receptor and elevated expression of
this integrin has been associated with invasive melanoma in
vitro (Felding-Habermann et al., 1992) and in vivo (Albelda
et al., 1990). Treatment of melanoma cells with an antibody
to the integrin causes an increase in their ability to invade
basement membrane matrices concomitant with an increase
in expression of a matrix degrading enzyme, 72 kDa
gelatinase, both at the mRNA and protein level (Seftor et al.,
1992). Furthermore, xv appears to be the important subunit
responsible for this finding. Our results suggest a stromal
distribution for the xvP3 receptor in colorectal tissue. A
moderate proportion (35%) of tumours showed decreased
expression of axvP3 in the stroma, but with preservation of
the av subunit immunoreactivity. Fewer tumours lost this
subunit and in four cases there was an increase in expression.
The increase in immunoreactivity observed with P5 suggests
an altered affinity of the av subunit. There appears to be a
preferential association of av with the P5 subunit in malig-
nant tissue and a corresponding reduction in expression of
the axvP3 complex. Breast and renal cell carcinomas show a
similar association (Pignatelli et al., 1992b; Korhonen et al.,
1992). It is tempting to speculate that the stromal localisation
of the avP3/xvP5 integrins may have a controlling influence
over the production and activity of metalloproteinases which
would aid in the enzymatic digestion of the extracellular
matrix. There is an increasing body of evidence to support
the stromal cells as being the source of these enzymes (Poul-
som et al., 1992) and thus the nearby localisation of these
particular integrins would imply an integral role. This would
be in keeping with the results seen in melanoma cell lines
(Seftor et al., 1992).
E-cadherin expression was preserved in the well and
moderately differentiated carcinomas. However, in all the
poorly differentiated carcinomas there was a marked decrease
in expression. The same tumours also showed loss of the a2
and P1 subunits. If tumours undergo a progressive loss of
differentiation during their genesis and subsequent growth
then it would appear from our findings that a2p1I loss is a
relatively early event in the dedifferentiation process and
E-cadherin loss a later occurrence. Van der Wurff (1992)
reported similar findings on E-cadherin in poorly
differentiated colorectal carcinomas but also suggested that
there was a gradual loss of E-cadherin from adenoma to high
grade carcinoma. Our results, although from comparable
small numbers, do not support that theory as the decrease in
expression of E-cadherin in our series was limited to the least
differentiated specimens. Gastric carcinoma shows a similar
distribution pattern to that which we found in colorectal
carcinoma (Shiozaki et al., 1991). Matsuura et al. (1992) have
shown that cells from a primary gastric tumour found in
ascites show an absence of staining for E-cadherin and
decreased intercellular adhesion. This latter finding suggests a
role for E-cadherin in the detachment and infiltrative process.
Although there was no significant correlation with metastasis
in our study the functional activity of the E-cadherin exp-
ressed is not known, i.e., immunoreactivity does not imply
functional activity. In signet ring cell lines mRNA expression
of E-cadherin is preserved even when a down-regulation in
protein expression is seen suggesting a defect at the post-
translational level. However, it may also be that in some
cases a defective protein is produced whose epitopes may still
be recognised by the monoclonal antibodies employed but
the protein is non-functional. Evidence for this comes from
the recent characterisation of a group of proteins termed
a-catenins which have been shown to be vital for the intercel-
lular adhesion mediated by E-cadherin (Shimoyama et al.,
1992). Cells lacking these proteins but expressing E-cadherin
do not adhere to one another, whereas after transfection with
the a-catenin cDNA, the same cells acquire strong cell-cell
adhesiveness (Hirano et al., 1992). Further evidence for a role
of E-cadherin in the invasive process comes from genetic
transfection studies. The introduction of a plasmid encoding
for E-cadherin-specific antisense RNA into non-invasive
transformed cells with high endogenous E-cadherin expres-
sion renders them invasive. This implies that the presence of
functional E-cadherin may have an invasion suppressor role
(Vleminckx et al., 1991).
Carcinoembryonic antigen (CEA) expression was present
in normal and malignant tissue. Furthermore, there was
accurate basolateral accentuation and some luminal staining
in the tumours. CEA is known to be a marker of functional
differentiation (Ahnen et al., 1987) and its distribution on the
luminal borders is therefore not surprising. The localisation
to the basolateral surface implies that this molecule may be
interacting with the matrix as well as functioning as an
intercellular adhesion molecule. This may be a reflection of
the several different forms of CEA that exist, perhaps with
different functions (Thompson & Zimmermann, 1988). Its
role, therefore, remains speculative, and further elucidation
of this is forming the basis of our current studies.
It is clear from the above discussion that many questions
remain unanswered about adhesion molecules in the
biological behaviour of colorectal carcinoma. From this
study we suggest that avP3/avP5 are largely expressed in the
stroma in colorectal tumours and this may be related to the
regulation of factors which control the invasive properties of
the neoplastic cells, a2,Bl integrin loss is a key early event in
the neoplastic process and this is related to the
dedifferentiation seen in many of these tumours. We also
provide further evidence that E-cadherin plays an important
role in the differentiation process and that its loss in vivo may
be a relatively late event when compared to integrin down-
regulation.
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